Dottikon Exclusive Synthesis AG

Dottikon Exclusive Synthesis AG (Switzerland) holds 2 active US FDA Type II Drug Master Files and 9 inactive, has DMF or CEP filings on record for 4 active ingredients, holds 1 active Type IV (excipient) Drug Master File and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Dottikon Exclusive Synthesis AG: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/dottikon-exclusive-synthesis-ag

Overview

Dottikon Exclusive Synthesis AG is a renowned Swiss company specializing in the production of high-quality active pharmaceutical ingredients (APIs) and intermediates. It provides a broad range of chemical synthesis services, emphasizing safety and sustainability.

Core services & business areas

Custom SynthesisProcess DevelopmentScale-UpManufacturing

Therapeutic areas

PharmaceuticalsChemical Synthesis

Active ingredients with DMF or CEP filings

Substances for which Dottikon Exclusive Synthesis AG holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Dottikon Exclusive Synthesis AG holds 2 active (11 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • OLSALAZINE SODIUMActive2004-09-13
  • ISOSORBIDE DINITRATE, DILUTEDActive1976-05-07
  • PENTAERYTHRITOL TETRANITRATE (DILUTED)Inactive2004-01-19
  • PANTOPRAZOLE SODIUM SESQUIHYDRATEInactive2003-08-14
  • T-3811A05Inactive2002-12-19
  • 5-METHOXYINDOL-3-ALDEHYDEInactive2002-01-22
  • DB5, IP-DB5Inactive2001-12-06
  • 2-CHLORO-3-(4 FLUOROBENZYL)-BENZIMIDE HYDROCHLORIDE(FBI HCL)Inactive2000-11-24
  • 6.7-DIHYDRO-3-ETHYL-2-METHYLINDOL-4-ONE (EMOTI)Inactive1996-12-30
  • ISOSORBIDE-5-NITRATE EXTENDED RELEASE PREMIXTURE 49.2%Inactive1994-03-18
  • DILUTED ISOSORBIDE MONONITRATEInactive1987-01-23

Excipient Drug Master Files

Dottikon Exclusive Synthesis AG holds 1 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • DOTTISOL (ISOSORBIDE DIMETHYL ETHER)Active2010-03-16

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Dottikon Exclusive Synthesis AG, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Dottikon Exclusive Synthesis AG in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Dottikon Exclusive Synthesis AG?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.